Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
There is an increasing understanding of the clinical correlations and potential mechanistic roles of specific members of the gut and tumoral microbiota in colorectal cancer (CRC) initiation, progression, and survival. However, we have yet to parlay this knowledge into better CRC outcomes through mi...
Guardado en:
Autores principales: | Caitlin A. Brennan, Geicho Nakatsu, Carey Ann Gallini Comeau, David A. Drew, Jonathan N. Glickman, Robert E. Schoen, Andrew T. Chan, Wendy S. Garrett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/350445d2f4bd45cbba8b496430834e5d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression
por: Caitlin A. Brennan, et al.
Publicado: (2021) -
The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management
por: Chun-Hui Sun, et al.
Publicado: (2019) -
Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum
por: Cody A. Despins, et al.
Publicado: (2021) -
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
por: Yaohui Gao, et al.
Publicado: (2021) -
Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer
por: Melike Kurt, et al.
Publicado: (2021)